Cite
Kaufmann E, Bartolomei F, Boon P, et al. European Expert Opinion on ANT-DBS therapy for patients with drug-resistant epilepsy (a Delphi consensus). Seizure. 2020;81:201-209doi: 10.1016/j.seizure.2020.08.015.
Kaufmann, E., Bartolomei, F., Boon, P., Chabardes, S., Colon, A. J., Eross, L., Fabó, D., Gonçalves-Ferreira, A., Imbach, L. L., Van Paesschen, W., Peltola, J., Rego, R., Theys, T., & Voges, B. (2020). European Expert Opinion on ANT-DBS therapy for patients with drug-resistant epilepsy (a Delphi consensus). Seizure, 81201-209. https://doi.org/10.1016/j.seizure.2020.08.015
Kaufmann, Elisabeth, et al. "European Expert Opinion on ANT-DBS therapy for patients with drug-resistant epilepsy (a Delphi consensus)." Seizure vol. 81 (2020): 201-209. doi: https://doi.org/10.1016/j.seizure.2020.08.015
Kaufmann E, Bartolomei F, Boon P, Chabardes S, Colon AJ, Eross L, Fabó D, Gonçalves-Ferreira A, Imbach LL, Van Paesschen W, Peltola J, Rego R, Theys T, Voges B. European Expert Opinion on ANT-DBS therapy for patients with drug-resistant epilepsy (a Delphi consensus). Seizure. 2020 Oct;81:201-209. doi: 10.1016/j.seizure.2020.08.015. Epub 2020 Aug 22. PMID: 32861153.
Copy
Download .nbib